medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-17-118-127medsovet-786Research ArticleАКУШЕРСТВО И ГИНЕКОЛОГИЯOBSTETRICS AND GYNECOLOGYПроисхождение, диагностика и методы лечения андрогензависимых поражений кожиOrigin, diagnostics and treatment of androgen-dependent skin lesionsКузнецоваИ. В.KuznetsovaI. V.noemail@neicon.ruНабиеваП. А.NabievaP. A.noemail@neicon.ruРоманцоваТ. И.RomantsovaT. I.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation201430122014017118127Copyright © Кузнецова И.В., Набиева П.А., Романцова Т.И., 20142014Кузнецова И.В., Набиева П.А., Романцова Т.И.Kuznetsova I.V., Nabieva P.A., Romantsova T.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/786

Гирсутизм, акне, себорея, алопеция у женщин развиваются, по общепринятому мнению, в прямой зависимости от степени нарушений метаболизма андрогенов. Однако группа андрогензависимых поражений кожи является неоднородной и включает в себя симптомы различного происхождения, связанные с различными заболеваниями и состояниями и далеко не всегда отражающие избыток продукции или действия мужских половых гормонов в женском организме. Какова бы ни была причина андрогензависимой дермопатии, наличие очевидного косметического дефекта наносит психическую травму пациентке. Это обусловливает актуальность проблемы андрогензависимых дермопатий. Вторая грань актуальности проблемы состоит в том, что андрогензависимые симптомы могут стать первым признаком серьезного заболевания, поэтому на них необходимо обращать внимание всем специалистам, а не только врачам-дерматологам. Фактически проблема андрогензависимых дермопатий носит междисциплинарный характер и представляет сферу интереса дерматологов, гинекологов, эндокринологов, психиатров, а также врачей общей практики.

Hirsutism, acne, seborrhea and alopecia in women, according to general opinion, are directly attributed to androgenic metabolic disorders. However, androgen-dependent skin lesions represent a heterogeneous group of diseases and include symptoms of various origin associated with various diseases and conditions, not always consisting in the excess production or action of male hormones in the female body. Whatever the cause of androgen-dependent dermopathy, presence of an obvious cosmetic defect causes trauma to the patient. That is why androgen-dependent dermopathy is a relevant issue. The other facet of its relevance lies in the fact that androgen-dependent symptoms may become the first sign of a serious illness, so they need to be considered by all specialists, not only dermatologists. In fact, the problem of androgen-dependent dermopathy is interdisciplinary and a matter of interest for dermatologists, gynecologists, endocrinologists, psychiatrists and general practitioners.

pregnancyhypovitaminosisvitamin & mineral supplementsандрогензависимая дермопатиягирсутизмакнеалопециясебореякомбинированные оральные контрацептивыантиандрогенные лекарственные средстваReferencesPawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dr no B. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol, 2004, 14(1): 4-12.Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dr no B. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol, 2004, 14(1): 4-12.Schaefer I, Rustenbach SJ, Zimmer L et al. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology, 2008, 217(2): 169-172.Schaefer I, Rustenbach SJ, Zimmer L et al. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology, 2008, 217(2): 169-172.Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs, 2006, 66: 903-912.Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs, 2006, 66: 903-912.Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med, 2005, 353: 2578-2588.Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med, 2005, 353: 2578-2588.Hahn S, Janssen OE, Tan S, Pleger K. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol, 2005, 153: 853-860.Hahn S, Janssen OE, Tan S, Pleger K. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol, 2005, 153: 853-860.Halvorsen JA, Dalgard F, Thoresen M. Is the association between acne and mental distress influenced by diet? Results from a crosssectional population study among 3775 late adolescents in Oslo, Norway BMC Public Health, 2009, 9: 340.Halvorsen JA, Dalgard F, Thoresen M. Is the association between acne and mental distress influenced by diet? Results from a crosssectional population study among 3775 late adolescents in Oslo, Norway BMC Public Health, 2009, 9: 340.Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review Obstet GynecolSurv, 2006, 61(11): 723-732.Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review Obstet GynecolSurv, 2006, 61(11): 723-732.Ching HL, Burke V, Stuckey BGA. Quality of Life and Psychological Morbidity in Women with Polycystic Ovary Syndrome: Body Mass Index, Age and the Provision of Patient Information Are Significant Modifiers. Clin Endocrinol, 2007, 66(3): 373-379.Ching HL, Burke V, Stuckey BGA. Quality of Life and Psychological Morbidity in Women with Polycystic Ovary Syndrome: Body Mass Index, Age and the Provision of Patient Information Are Significant Modifiers. Clin Endocrinol, 2007, 66(3): 373-379.Brinton LA, Moghissi KS, Westhoff CL, Lamb EJ, Scoccia B. Cancer Risk Among Infertile Women with Androgen Excess or Menstrual Disorders (including Polycystic Ovary Syndrome). Fertil Steril, 2010, 94(5): 1787-1792.Brinton LA, Moghissi KS, Westhoff CL, Lamb EJ, Scoccia B. Cancer Risk Among Infertile Women with Androgen Excess or Menstrual Disorders (including Polycystic Ovary Syndrome). Fertil Steril, 2010, 94(5): 1787-1792.Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010, 362: 485-493.Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010, 362: 485-493.Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362: 1090-1101.Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362: 1090-1101.Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004, 89: 453-462.Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004, 89: 453-462.Miller WL, Auchus RJ. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocr Rev 2011, 32(1): 81-151.Miller WL, Auchus RJ. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocr Rev 2011, 32(1): 81-151.Nissar AS, Heath JA, Pall M. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93: 1939-1945.Nissar AS, Heath JA, Pall M. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93: 1939-1945.Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005, 37: 438-444.Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005, 37: 438-444.Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W. Androgen generation in adipose tissue in women with simple obesity -a site -specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol. 2004, 183: 331-342.Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W. Androgen generation in adipose tissue in women with simple obesity -a site -specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol. 2004, 183: 331-342.Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Nader R, Buring JE, Gaziano JM, Liu S. Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men. NEnglJMed. 2009, 361(12): 1152-1163.Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Nader R, Buring JE, Gaziano JM, Liu S. Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men. NEnglJMed. 2009, 361(12): 1152-1163.Hahn S, Haselhorst U, Tan S et al. Low Serum 25-Hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006, 114: 577-583.Hahn S, Haselhorst U, Tan S et al. Low Serum 25-Hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006, 114: 577-583.Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009, 94(12): 4776-4784.Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009, 94(12): 4776-4784.Stener-Victorin E, ran Holm G, Labrie F et al. Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome? J Clin Endocrinol Metab 2010, 95: 810-819.Stener-Victorin E, ran Holm G, Labrie F et al. Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome? J Clin Endocrinol Metab 2010, 95: 810-819.Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004, 191: 1914-1920.Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004, 191: 1914-1920.Takeda N, Jain R, LeBoeuf MR, Padmanabhan A, Wang Q, Li L et al. Hopx expression defines a subset of multipotent hair follicle stem cells and a progenitor population primed to give rise to K6+ niche cells. Development 2013, 140(8): 1655-1664.Takeda N, Jain R, LeBoeuf MR, Padmanabhan A, Wang Q, Li L et al. Hopx expression defines a subset of multipotent hair follicle stem cells and a progenitor population primed to give rise to K6+ niche cells. Development 2013, 140(8): 1655-1664.Yaykasli KO, Turan H, Kaya E, Hatipoglu OF. Polymorphisms in the promoters of MMP-2 and TIMP-2 genes in patients with acne vulgaris. Int J Clin Exp Med 2013,25,6(10): 967-972.Yaykasli KO, Turan H, Kaya E, Hatipoglu OF. Polymorphisms in the promoters of MMP-2 and TIMP-2 genes in patients with acne vulgaris. Int J Clin Exp Med 2013,25,6(10): 967-972.James WD. Acne. N EnglJ Med 2005, 352 (14): 1463-1472.James WD. Acne. N EnglJ Med 2005, 352 (14): 1463-1472.Schmitt JV, Masuda PY, Miot HA. Acne in women: clinical patterns in different age-groups. An Bras Dermatol 2009, 84(4).Schmitt JV, Masuda PY, Miot HA. Acne in women: clinical patterns in different age-groups. An Bras Dermatol 2009, 84(4).

The authors declare that there are no conflicts of interest present.